Open-label pilot study of combination therapy with rosiglitazone and bexarotene in the treatment of cutaneous T-cell lymphoma.
Open-label pilot study of combination therapy with rosiglitazone and bexarotene in the treatment of cutaneous T-cell lymphoma.
复制标题
DOI：
10.1016/j.jaad.2006.10.033
复制
发表时间：
2007-04
影响因子：
13.8
通讯作者：
Jacob A Sepmeyer;J. Greer;T. Koyama;J. Zic
中科院分区：
文献类型：
--
作者：
Jacob A Sepmeyer;J. Greer;T. Koyama;J. Zic
